SCHEMBL19003490

SCHEMBL19003490

CC1CC/C=C/CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2008155 1.00
SCHEMBL1904497 1.00
SCHEMBL3860149 0.94
SCHEMBL3860150 0.94
SCHEMBL3859861 0.92
SCHEMBL3859856 0.92
SCHEMBL3862161 0.89 ACHE (0.32)
SCHEMBL3868647 0.89 ACHE (0.32)
SCHEMBL3868644 0.89 ACHE (0.32)
SCHEMBL3862157 0.89 ACHE (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024006272-A1 β-GLUCURONIDE LINKER-PAYLOADS, PROTEIN CONJUGATES THEREOF, AND METHODS THEREOF SUTRO BIOPHARMA, INC. (US) 2024-01-04 WO disclosed
WO-2023158305-A1 MASKED IL12 PROTEIN TAGWORKS PHARMACEUTICALS B.V. (NL) 2023-08-24 WO disclosed
WO-2023077126-A1 TRANS-CYCLOOCTENE CONJUGATES TAMBO, INC. (US) 2023-05-04 WO disclosed
WO-2020256544-A1 TETRAZINES FOR HIGH CLICK RELEASE SPEED AND YIELD TAGWORKS PHARMACEUTICALS B.V. (NL) 2020-12-24 WO disclosed
WO-2017106427-A1 METHODS FOR INDUCING BIOORTHOGONAL REACTIVITY FOX JOSEPH (US) 2017-06-22 WO disclosed